Vaxart Investors Can Tweak Stock Claims Over COVID Vaccine
By Craig Clough · May 13, 2021, 9:42 PM EDT
A group of investors suing Vaxart Inc. can amend their complaint to more clearly allege that the company artificially inflated its stock price through a press release with a deceptive headline...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login